Biotech Analysts Devarakonda and Jahangiri, along with a hematologist and oncologist expert, focus on MDS (relevant companies BMY, KROS, ABBV, CRIS) on an Analyst/Industry conference call to be held on February 26 at 12 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BMY:
- Aurora Cannabis CFO Glen Ibbott to step down, Simona King to succeed
- Bristol Myers says FDA accepts sNDA for KRAZATI in combination with cetuximab
- Bristol-Myers Squibb Announces New Senior VP and Controller
- Bristol-Myers Squibb Warns Against Tutanota’s Mini-Tender Offer
- Bristol Myers urges shareholders to reject ‘mini-tender’ offer by Tutanota